(Q33702177)

28 July 2017

1 reference

title

Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections (English)

1 reference

28 July 2017

0 references

Tümmler B

1

1 reference

PubMed ID

10431168

28 July 2017

Kiewitz C

series ordinal

2

1 reference

28 July 2017

1 August 1999

1 reference

Trends in Molecular Medicine

28 July 2017

1 reference

28 July 2017

5

1 reference

28 July 2017

351-358

1 reference

28 July 2017

8

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

28 July 2017

1 reference

7 January 2021

CFTR:a multifaceted epithelial molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Understanding how cystic fibrosis mutations cause a loss of Cl- channel function.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Common virulence factors for bacterial pathogenicity in plants and animals

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

A major Pseudomonas aeruginosa clone common to patients and aquatic habitats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Cell-to-cell signaling and Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

The involvement of cell-to-cell signals in the development of a bacterial biofilm

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

The exoenzyme S regulon of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

The role of neutrophil elastase in chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

A physical genome map of the Burkholderia cepacia type strain

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Burkholderia cepacia. Management issues and new insights.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Erythromycin treatment in diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901506-3

7 January 2021

10.1016/S1357-4310(99)01506-3

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10431168